Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check6 days agoChange DetectedAdds two new entries to the record history: Contacts/Locations and Study Status, dated 2026-05-05 and 2026-05-06, respectively. It also removes the historical entry dated 2026-05-01.SummaryDifference0.1%

- Check13 days agoChange DetectedOn 2026-05-01, Contacts/Locations and Study Status were added to the study record history. This update provides visibility into where the study is conducted and its current status, aiding users in understanding who to contact and the study’s progress.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site/version change without changing the study record content.SummaryDifference0.0%

- Check27 days agoChange DetectedA new revision entry v3.5.2 with a Study Status update was added (dated 2026-04-13), and the previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded new history entries (versions 318–320) with updated Study Status for 2026-04-07 to 2026-04-09.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded several new history entries (versions 312–316) to the Record History, documenting updates to Contacts/Locations and Study Status.SummaryDifference0.2%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.